La Jolla Pharmaceutical Analysis

LJPCDelisted Stock  USD 6.22  0.00  0.00%   
La Jolla Pharmaceutical is overvalued with Real Value of 4.63 and Hype Value of 6.22. The main objective of La Jolla delisted stock analysis is to determine its intrinsic value, which is an estimate of what La Jolla Pharmaceutical is worth, separate from its market price. There are two main types of La Jolla's stock analysis: fundamental analysis and technical analysis. Fundamental analysis focuses on the financial and economic factors that affect La Jolla's performance, such as revenue growth, earnings, and financial stability. Technical analysis, on the other hand, focuses on the price and volume data of La Jolla's stock to identify patterns and trends that may indicate its future price movements.
The La Jolla stock is traded in the USA on NASDAQ Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. La Jolla is usually not traded on Thanksgiving Day, Christmas Day, New Year 's Day, Dr . Martin Luther King Jr 's Birthday, Washington 's Birthday, Good Friday, Memorial Day, Juneteenth Holiday, Independence Day, Labour Day. LJPC Stock trading window is adjusted to America/New York timezone. Here, you can get updates on important government artifacts, including earning estimates, SEC corporate filings, announcements, and La Jolla's ongoing operational relationships across important fundamental and technical indicators.
  
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in american community survey.

LJPC Stock Analysis Notes

About 72.0% of the company shares are owned by institutional investors. The company recorded a loss per share of 1.44. La Jolla Pharmaceutical last dividend was issued on the 31st of August 2010. The entity had 1:50 split on the 14th of January 2014. La Jolla Pharmaceutical Company engages in the development and commercialization of therapies that improve outcomes in patients suffering from life-threatening diseases. La Jolla Pharmaceutical Company was incorporated in 1989 and is based in Waltham, Massachusetts. La Jolla operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 61 people. To find out more about La Jolla Pharmaceutical contact George Tidmarsh at 617 715-3600 or learn more at www.ljpc.com.

La Jolla Pharmaceutical Investment Alerts

Many investors view ongoing market volatility as an opportunity to purchase more delisted stocks at a favorable price or short it to generate a bearish trend profit opportunity. If you are one of those investors, make sure you clearly understand the position you are entering. La Jolla's investment alerts are automatically generated signals that are significant enough to either complement your investing judgment regarding La Jolla Pharmaceutical or challenge it. These alerts can help you understand what you are buying and avoid costly mistakes.
La Jolla is not yet fully synchronised with the market data
La Jolla has a very high chance of going through financial distress in the upcoming years
About 72.0% of the company shares are owned by institutional investors

LJPC Market Capitalization

The company currently falls under 'Small-Cap' category with a current market capitalization of 171.2 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate La Jolla's market, we take the total number of its shares issued and multiply it by La Jolla's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.

LJPC Profitablity

La Jolla's profitability indicators refer to fundamental financial ratios that showcase La Jolla's ability to generate income relative to its revenue or operating costs. If, let's say, La Jolla is currently losing money, the management's focus should be on how to reverse that trend. However, when revenue exceeds expenses, La Jolla's executives or investors may be in less hurry to break that information down - which is where profitability analysis comes into play. Gaining a greater understanding of La Jolla's profitability requires more research than a typical breakdown of La Jolla's financial statements. By doing a profitability analysis, companies can identify areas needing attention, and investors can make a profitable trade.
The company has Profit Margin (PM) of 10.08 %, which can signify that it executes well on its competitive strategies and has good control over its expenditures. This is very large. Similarly, it shows Operating Margin (OM) of 4.68 %, which suggests for every 100 dollars of sales, it generated a net operating income of $4.68.

About LJPC Stock Analysis

Stock analysis is the technique used by a trader or investor to examine and evaluate how La Jolla prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling LJPC shares will generate the highest return on investment. We also built our delisted stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Delisted Stock such as La Jolla. By using and applying LJPC Stock analysis, traders can create a robust methodology for identifying LJPC entry and exit points for their positions.
La Jolla Pharmaceutical Company engages in the development and commercialization of therapies that improve outcomes in patients suffering from life-threatening diseases. La Jolla Pharmaceutical Company was incorporated in 1989 and is based in Waltham, Massachusetts. La Jolla operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 61 people.

Be your own money manager

As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding La Jolla to your portfolios without increasing risk or reducing expected return.

Did you try this?

Run Price Ceiling Movement Now

   

Price Ceiling Movement

Calculate and plot Price Ceiling Movement for different equity instruments
All  Next Launch Module
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in american community survey.
You can also try the Risk-Return Analysis module to view associations between returns expected from investment and the risk you assume.

Other Consideration for investing in LJPC Stock

If you are still planning to invest in La Jolla Pharmaceutical check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the La Jolla's history and understand the potential risks before investing.
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Fundamental Analysis
View fundamental data based on most recent published financial statements
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences